Literature DB >> 12117112

Interleukin-4 and interferon-gamma gene expression in summer pasture-associated obstructive pulmonary disease affected horses.

R E Beadle1, D W Horohov, S D Gaunt.   

Abstract

We hypothesised that horses affected with summer pasture-associated obstructive pulmonary disease (SPAOPD) react to an allergen or allergens in their summer environment that is either absent or present at lower levels in their winter environment; and that such allergens stimulate SPAOPD-affected horses to produce a different T helper lymphocyte cytokine profile from that of control horses. The primary objective of this study was to determine the cytokine mRNA profile of T helper lymphocytes obtained from summer pasture-associated obstructive pulmonary disease (SPAOPD) affected horses when 1) the horses were showing signs of disease (summer) and 2) they were in clinical remission (winter). A further objective was to determine the differences between cytokine mRNA T helper lymphocyte profiles of control and affected horses in the summer and winter seasons. Interleukin 4 (IL-4) and interferon-gamma (IFN-gamma) mRNA expression levels were increased in bronchoalveolar lavage fluid (BALF) and peripheral blood mononuclear cell (PBMC) samples of affected horses during disease expression. No significant amounts of IL-5 mRNA were detected in any of the samples. These results suggest that there is an allergic component to SPAOPD of horses and that appropriate manipulation of the immune system could offer hope for treatment and prevention of the disease in the future. Further research studies will be needed to determine the most appropriate treatments to use to alter the antigen-stimulated cytokine profile being expressed by SPAOPD-affected horses or to alter the effects that these cytokines produce.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12117112     DOI: 10.2746/042516402776249119

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  5 in total

1.  Equine bronchoalveolar lavage cytokines in the development of recurrent airway obstruction.

Authors:  M Pietra; A Peli; A Bonato; A Ducci; S Cinotti
Journal:  Vet Res Commun       Date:  2007-08       Impact factor: 2.459

Review 2.  Modeling asthma: Pitfalls, promises, and the road ahead.

Authors:  Helene F Rosenberg; Kirk M Druey
Journal:  J Leukoc Biol       Date:  2018-02-16       Impact factor: 4.962

Review 3.  Pulmonary Remodeling in Equine Asthma: What Do We Know about Mediators of Inflammation in the Horse?

Authors:  Ann Kristin Barton; Heidrun Gehlen
Journal:  Mediators Inflamm       Date:  2016-12-07       Impact factor: 4.711

4.  Immunohistochemical Expression of Neurokinin-A and Interleukin-8 in the Bronchial Epithelium of Horses with Severe Equine Asthma Syndrome during Asymptomatic, Exacerbation, and Remission Phase.

Authors:  Maria Morini; Angelo Peli; Riccardo Rinnovati; Giuseppe Magazzù; Noemi Romagnoli; Alessandro Spadari; Marco Pietra
Journal:  Animals (Basel)       Date:  2021-05-12       Impact factor: 2.752

5.  An Integrative miRNA-mRNA Expression Analysis Reveals Striking Transcriptomic Similarities between Severe Equine Asthma and Specific Asthma Endotypes in Humans.

Authors:  Matthias F Hulliger; Alicja Pacholewska; Amandine Vargas; Jean-Pierre Lavoie; Tosso Leeb; Vincent Gerber; Vidhya Jagannathan
Journal:  Genes (Basel)       Date:  2020-09-28       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.